The role of bisphosphonates in breast and prostate cancers.

@article{Brown2004TheRO,
  title={The role of bisphosphonates in breast and prostate cancers.},
  author={Janet Elizabeth Brown and Helen L. Neville-Webbe and Robert Coleman},
  journal={Endocrine-related cancer},
  year={2004},
  volume={11 2},
  pages={207-24}
}
Bisphosphonate drugs are a group of pyrophosphate analogues which bind avidly to hydroxyapatite bone mineral surfaces and their major action is to inhibit osteoclast activity and thus bone resorption. In oncology, their role in metastatic bone disease is well established, but there is increasing interest in their potential role in preventing and treating cancer-induced bone loss and their possible anti-tumour effects. Metastatic bone disease is associated with a variety of skeletal… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 36 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 130 references

Pamidronate to prevent bone loss in men receiving gonadotropin releasing hormone agonist therapy for prostate cancer

  • MR Smith, FJ McGovern, +5 authors JS Finkelstein
  • New England Journal of Medicine
  • 2001
Highly Influential
3 Excerpts

The effects of intravenous bisphosphonate treatment on the bone microenvironment in patients with breast cancer and bone metastases

  • SP Jagdev, PI Croucher, RE Coleman
  • European Journal of Cancer
  • 2001
Highly Influential
5 Excerpts

Similar Papers

Loading similar papers…